Delivery Order SPE2DB20D9127-SPE2DB25FPQX4
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,583.28 firm fixed-price delivery order is for 4,568,311,491 units of Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of May 21, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,444.16 firm fixed-price delivery order is for the provision of 4567653313 - Omeprazole DR 10 mg Capsule 30s, a prescription medication. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,111.04, is for the delivery of 4,568,057,868 units of Omeprazole DR 10 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,111.04 contract is for the delivery of Omeprazole DR 10 mg capsules. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical products, including branded and generic prescription drugs,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of omeprazole delayed-release 10 mg capsules to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,222.08 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) for the supply of 4568384330 - Omeprazole DR 10 mg Capsule 30s. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Omeprazole DR 10 mg capsules, a prescription medication, with a ceiling value of $4,222.08 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a significant...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,248.00, is for the delivery of 4,567,792,099 units of the drug Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract, valued at $1,055.52, is for the delivery of Omeprazole DR 10 mg capsules. The contract is a delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $1,055.52 contract is for the delivery of 30-count capsules of Omeprazole DR 10 mg. The contract has an ultimate completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in supplying a range of pharmaceutical products, including branded and generic prescription drugs,...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPQX4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,055.52 firm fixed-price delivery order is for the supply of Omeprazole DR 10 mg capsules. The contract has a completion date of July 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.
Generated 10/12/25, 1:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/10/25 |